The article provides a review of the literature on the topic of diabetic retinopathy. In this regard, reliable literature is used and current information is highlighted.

diabetic retinopathy, type 2 diabetes mellitus, dynamics, symptoms.

BrennerB. et al. Renaal Study Investigators: effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy // N. Engl. J. Med. – 2001. –Vol. 345. – P. 861–869.

Castello I.B. Hyperlipidemia: a risk factor for chronic allograft dysfunction // Kidney mt. –2002.–Vol. 61 (suppl. 80). – P. 1923–1928.

Coresh J., ActorB.C., GreenT. Etal. Prevalence chronic kidney disease and decreased kidney function in the abult US population: third national health and nutrilion examination survey // Am. J. Kidney Dis. – 2003. – N 41. – Р. 1–12.

Decochez K., Truyen I., AuweraB.V. et al. (Belgian diabetes Relgian) Combined positivity for HLA DQ2( DQ8 and 1A-2 antibodies defines population and high risk of developing type 1 diabetes // Diabetologia. – 2005. – Vol. 48, N 4. – Р. 687–690.

Forhan J.M., Balkan B. et al. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin anct in both men and women? // J. Cardiovasc. risk. – 2001. – Vol. 8. – P. 1007–1009.

Go A.S., Chertov G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization // N. Engl. J. Med. – 2004. – Vol. 351 (suppl 13). – P. 1296–1304.

Halteren A.G.S., Kardol M.J., Mulder A. Homing of human autoreactive T-cells into pancreatic tissue of NOD-SCID mice // Diabetologia. – 2005. – Vol. 48, Suppl. 1. – P. 75–82.

Han D., Hamilton R.T., Lam P.J. et al. Lipoic acid: energy production antioxidant activity and health effects. – N.Y.: CRC Press, 2008. – Р. 293–315.

Januzewsky A.S., Alderson N.L., Metz T.O.et al. Role of Lipides in chemical modification of proteins and development of complications in diabetes // Biochem. Soc. Trans. – 2003. – Vol. 31, N 6. – Р. 1413–1416.

Sjoilie A.K., Klein R., Porta M. et al. Direct Programme Study Group, Effect of Candesartan on progressin and regression retinopathy in type 2 diabetes (DIRECT-Protect2); a randomised placebocontrolled trial // Lancet. – 2008. – Vol. 372. – P. 1385–1393.

Verma S., Fedak P.W.M., Eeisel R.D. Fundamentals of reperfusion injury for the clinical cardiologist // Circulation. – 2002. – Vol. 105. – P. 2332–2336.

Yamasaki M., Kawabe A., Nishimoto t al. Dihidroalpha-lipoic acid has more patent cytotoxicity than alpha-lipoic acid // In Vitro Cell. Dev. Biol. Amm. – 2009. – Vol. 45, N 5–6. – P. 275–280.